5 Questions
What is the primary focus of this Clinical Guideline?
Glycemic control in the neonate receiving parenteral nutrition
What is a potential consequence of severe hyperglycemia in neonates?
Electrolyte imbalance and dehydration
What is the elevated risk of in neonates receiving parenteral nutrition?
Hyper- and hypoglycemia
What is a potential outcome of untreated hypoglycemia in neonates?
Neurodevelopmental impairment
What population is particularly susceptible to the deleterious effects of hyperglycemia?
Premature infants with low birth weight
Study Notes
Background of Clinical Guideline
- The guideline addresses glycemic control in neonates (within the first month of life) receiving parenteral nutrition (PN).
- Neonates receiving PN are at an elevated risk of hyper- and hypoglycemia.
Risks of Hyper- and Hypoglycemia
- Untreated hyper- or hypoglycemia can lead to undesirable clinical outcomes.
- Prolonged or symptomatic hypoglycemia may result in neurodevelopmental impairment.
- Severe hyperglycemia can cause osmotic diuresis, leading to dehydration and electrolyte imbalance.
Special Considerations for Premature Infants
- Hyperglycemia in premature infants, especially those with very low birth weight (VLBW), may have additional consequences.
This quiz covers the clinical guidelines for glycemic control in neonates receiving parenteral nutrition, focusing on the prevention and management of hyper- and hypoglycemia. It's essential for healthcare professionals to understand the unique considerations for this high-risk population.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
